Heart Disease

HighLife

To evaluate a new valve in patients with moderate-severe or severe mitral regurgitation and at high surgical risk.

Trial overview

Topic

Heart failure due to mitral valve regurgitation

Eligibility criteria

To be considered for this study you must meet the following criteria:

  • 18 years of age or older
  • Have moderate to severe mitral regurgitation
  • Unable to undergo open heart surgery

Study details

Your participation in this study would be for approximately five years.

You will need to undergo a procedure to have the valve inserted and stay in hospital for up to 2-3 days. You will then be seen in the clinic at 30 days, 3 months, 6 months and 12 months and then annually up to 5 years.  During these visits you will be asked about your health and medications and have a physical examination, blood test, ultrasound of your heart and ECG.

You will be reimbursed for travel and study-related expenses.

Further information

For further information regarding this clinical trial click here.

Location

Leabrook (Cardiology)

Wesley Hospital Auchenflower (Cardiology Consulting)

Murdoch (Cardiology)

North Shore (Cardiology)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.